These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5706063)

  • 21. Immunologic enhancement of tumor xenografts by pepsin-degraded immunoglobulin.
    Broder S; Whitehouse F
    Science; 1968 Dec; 162(3861):1494-5. PubMed ID: 4177430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of growth and regression of Ehrlich ascites carcinoma transplanted intraperitoneally in rats.
    Janik P; Dabrowski M; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):717-23. PubMed ID: 5957993
    [No Abstract]   [Full Text] [Related]  

  • 23. Some antigenic properties of the membrane of mouse erythrocytes and Ehrlich ascites tumor cell.
    Furusawa M
    Exp Cell Res; 1967 Aug; 47(1):63-74. PubMed ID: 6038820
    [No Abstract]   [Full Text] [Related]  

  • 24. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
    Bregula U; Slowikowska G; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
    [No Abstract]   [Full Text] [Related]  

  • 25. Surface antigen expression in malignant sublines derived from hybrid cells of low malignancy.
    Grundner G; Fenyö EM; Klein E; Bregula U; Harris H
    Exp Cell Res; 1971 Oct; 68(2):315-22. PubMed ID: 4108039
    [No Abstract]   [Full Text] [Related]  

  • 26. Antitumour effect of different corynebacterial immunostimulants in non isogenic mouse-tumour-system. (Short communication).
    Géresi M; Réthy L; Ecsy R; Gelencsér F; Padányi M; Pogány I; Bácskai L; Réthy LA
    Acta Vet Acad Sci Hung; 1981; 28(3):281-3. PubMed ID: 7258017
    [No Abstract]   [Full Text] [Related]  

  • 27. Circadian rhythm in survivorship after removal of Ehrlich ascites tumor.
    Brown HR
    Transplantation; 1974 Mar; 17(3):322-3. PubMed ID: 4814198
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anti-cancerous activity and specificity of anti-embryonal serums].
    Sédallian JP
    C R Seances Soc Biol Fil; 1966; 160(11):2092-6. PubMed ID: 4228139
    [No Abstract]   [Full Text] [Related]  

  • 29. A naturally occurring complement dependent human IgM macroglobulin inhibitory to Ehrlich ascites tumor cells.
    Goff MM; Armentrout SA
    J Clin Lab Immunol; 1982 Dec; 9(3):163-7. PubMed ID: 7166749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the mechanism of prolonged survival of allografts from tumor-bearing donors.
    Robinson E; Golakai VK; Schlesinger M
    Cancer Res; 1968 Mar; 28(3):462-4. PubMed ID: 4867924
    [No Abstract]   [Full Text] [Related]  

  • 31. Acquired immunity to Ehrlich ascites tumor in mice after treatment with fresh or sonized tumor cells at various ages.
    Yasuhira K
    Acta Tuberc Jpn; 1966 Dec; 16(2):78-84. PubMed ID: 5984181
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental contribution to the analysis of the immunological reactions of ocular structures in presence of heterologous tumors. (a). Mouse ascites tumor graft in the rabbit cornea. (b). Mouse ascites tumor wrapped in autoplastic membrane grafted in the anterior chamber of the guinea pig eye].
    Claudio C; Corrado F
    Riv Anat Patol Oncol; 1969; 35():292-309. PubMed ID: 5404378
    [No Abstract]   [Full Text] [Related]  

  • 33. [Morphological evaluation of the internal organs of mice with Ehrlich carcinoma treated with rat agammaglobulin antisarcoma serum].
    Niepolomski W; Szczurek Z; Czaplicki J
    Patol Pol; 1972; 23(2):143-50. PubMed ID: 5034469
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction of resistance against Ehrlich carcinoma by tumor cells sensitized with immunized rabbit serum.
    Kato N; Ito S; Mizuno D
    Gan; 1972 Apr; 63(2):173-9. PubMed ID: 5070236
    [No Abstract]   [Full Text] [Related]  

  • 35. Globulin coating in vivo of Ehrlich's ascites carcinoma cells.
    Thunold S
    Transplantation; 1968 Aug; 6(5):716-27. PubMed ID: 4179287
    [No Abstract]   [Full Text] [Related]  

  • 36. Replication of influenza A virus in suspensions of Ehrlich ascites tumor cells kept in vitro. Results obtained by the fluorescent antibody technique.
    Haller O
    Pathol Microbiol (Basel); 1970; 36(1):1-26. PubMed ID: 4923885
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of subcutaneous transplants of Ehrlich carcinoma on the survival time of mice with intraperitoneal transplants of the same tumour.
    Hartveit F; Halleraker B
    J Pathol; 1971 Oct; 105(2):85-93. PubMed ID: 5135341
    [No Abstract]   [Full Text] [Related]  

  • 38. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
    Weiland E; Weiland F
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
    [No Abstract]   [Full Text] [Related]  

  • 39. Investigations on mononuclear cells of animals sensitized against homologous normal tissue transplants and tumor transplants.
    Warnatz H
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):748-52. PubMed ID: 5334579
    [No Abstract]   [Full Text] [Related]  

  • 40. Preliminary report. Antigenicity of the mice Ehrlich ascitic tumor cell nuclei.
    Zitnan D; Cebecauer L; Ujházy V
    Neoplasma; 1969 Jun; 16(3):339-41. PubMed ID: 4981697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.